Please login to the form below
GfK
This page shows the latest GfK news and features for those working in and with pharma, biotech and healthcare.
Ipsos to buy GfK Research divisions
It will also buy GfK’s customer experience business that operates around employee satisfaction, customer satisfaction and loyalty, and mystery shopping services. ... GfK’s innovation arm, which incorporates research in car clinics, VR technology,
Latest news
-
Strong sales increase for connected mobile health devices
In the UK, Germany, France and the Netherlands the number of mobile-connected blood pressure monitors purchased last year rose by 42 per cent, according GfK. ... Netherlands. Overall, however, GfK found that connected devices currently account for only a
-
Risk sharing: mitigate uncertainty
The Author. Dr Marco Rauland is head of pricing &market access, GfK HealthCare.
-
BOBI rewards best in the business
Two Best Newcomer Awards will be awarded for:. • Best Industry Newcomer - sponsored by GfK Healthcare.
-
Kantar regroups
TNS was taken over in a £1.1bn deal last October by WPP, owners of Kantar, after German company, GfK, failed to come up with a cash offer to buy TNS
-
Make it obvious
Added extras. When it comes to the stopping power of an advert, GfK Martin Hamblin uses the key measures of interest and impact to evaluate its success. ... The survey. The data for gp monitor was gathered using Generator, the monthly omnibus from GfK
More from news
Approximately 1 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
Revolution or evolution: is it the end of SMR and ASMR in France?
The Author. Caroline Conti is strategy consultant GfK Bridgehead. ... She can be contacted at Caroline.Conti@gfk.com.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Kelly Warth joins the P/S/L Group network
GfK. In her most recent role as UK head of health and global business development at GfK, Warth developed and managed the overall business, as well as built key relationships with
-
HRW bolsters global management team
GfK Healthcare and Ipsos Healthcare.
-
Daniel Sterzi joins Kantar Health Spain
Prior to this, he worked for GFK Customer Research France and Vivo (Telefónica Brazil), where he began his career as a marketing analyst.
-
Research Partnership appoints three new office heads
Both Christine Naegle and Birgit Eschmann join from GfK Healthcare and respectively will head up the newly established LA office and the San Francisco office. ... Naegle (pictured right) spent more than 20 years at GfK serving in a variety of market
-
Hall & Partners announces new senior hires
McPartland, who began his career at GfK NOP, brings over 25 years' experience to H&P Health, much of which working with blue chip pharma companies.
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Consumer health specialist joins Research Partnership Inc
Previously Jennifer has held senior positions at Healogix, AMC Global and GfK/Arbor.
-
GfK HealthCare
GfK is one of the world’s leading market research companies, with more than 11, 000 experts working to discover new insights into the way people live, think and shop, in ... GfK is constantly innovating and using the latest technologies and the
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Janssen’s single tablet combination shows promise in phase 3 PAH study
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- How to make sure your adverts for clinical trials are compliant
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
